Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells in Drug Discovery & Toxicity Screening 2018

Stem Cells in Drug Discovery & Toxicity Screening 2018

Date: Thursday, 4 October 2018 - Friday, 5 October 2018
Location: Coronado Island, California


Keynote Speakers

Linda Griffith

Linda Griffith
Professor, Massachusetts Institute of Technology (MIT)

Gary Gintant

Gary Gintant
Senior Research Fellow, Abbvie

Reyk Horland

Reyk Horland
CEO, TissUse GmbH

Paul Gatenholm

Paul Gatenholm
Professor, Director of 3D Bioprinting Center, Chalmers University of Technology, Sweden; CEO, CELLHEAL AS, Norway

Nancy Allbritton

Nancy Allbritton
Kenan Professor of Chemistry and Biomedical Engineering and Chair of the Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State University

Shoji Takeuchi

Shoji Takeuchi
Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo

Roger Kamm

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

James Hickman

James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos

Mark Bradley

Mark Bradley
Professor of Therapeutic Innovation, Precision Healthcare University Research Institute, Queen Mary University of London

Norio Nakatsuji

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Overview

SELECTBIO Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers from around the world focusing on the emerging technologies and applications in cellular analysis.

The following conferences are co-Located and concurrent and Delegates can Participate, Mix-and-match presentations and network extensively.

Co-Located, Concurrent Conference Tracks:
  • Organ-on-a-Chip World Congress 2018
  • 3D-Bioprinting 2018
  • Stem Cells in Drug Discovery and Toxicity Screening 2018
  • 3D-Culture & Organoids 2018
Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.

Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.

Information and Local Registration Facilities for this Conference are also available in:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Agenda Topics

  • 3D-Cell Culture Based Models
    • Technologies in 3D-Cell Culture
  • iPSC-derived Cells for Toxicity Testing & Screening
  • Screening Technologies, Instrumentation and Reagents
  • Stem Cells in Drug Discovery and Development
  • Use of Microfluidics Organs-on-Chips for Toxicity Screening

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Ulrich Broeckel, Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin
Guohao Dai, Associate Professor, Department of Bioengineering, Northeastern University
Toshihiko Ezashi, Research Associate Professor, The University of Missouri
Robert Halliwell, Professor of Neuroscience and Clinical Pharmacology, University of The Pacific


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2018-10-04 00:00:002018-10-05 00:00:00Europe/LondonStem Cells in Drug Discovery and Toxicity Screening 2018Stem Cells in Drug Discovery and Toxicity Screening 2018 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com